Physician profile
Colleen E Cherry
NPI 1700103454
$2,959.29
in general payments reported to CMS, 2019-2025
24 companies · $683 in 2025
The $683 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $151 · 2021: $176 · 2022: $457 · 2023: $730 · 2024: $442 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,790 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,789.69 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $523.37 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $397.34 | 2019-2023 | Lo Loestrin Fe, Liletta, Orilissa |
| Mayne Pharma Commercial LLC | $342.59 | 2021-2025 | |
| Optumhealth Care Solutions, LLC | $341.04 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Exeltis, USA INC. | $314.09 | 2020-2025 | Slynd |
| Therapeuticsmd, INC. | $176.61 | 2019-2022 | |
| Organon LLC | $157.75 | 2022-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $90.79 | 2019-2025 | |
| Aspira Women'S Health INC | $87.59 | 2023 | Ova1 |
| Hologic Sales and Service, LLC | $84.02 | 2020-2024 | Aptima |
| Myovant Sciences INC. | $77.12 | 2022 | |
| Millicent US INC | $59.39 | 2020-2025 | Femlyv |
| Pfizer INC. | $42.45 | 2022-2023 | |
| Lupin INC. | $32.91 | 2019 | |
| Masimo Corporation | $32.32 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $26.77 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $26.04 | 2019-2020 | |
| Coopersurgical, INC. | $25.71 | 2023 | Paragard T 380a |
| Solventum Corporation | $21.59 | 2025 | Prevena |
| Amgen INC. | $21.19 | 2024 | Prolia, Evenity |
| Takeda Pharmaceuticals U.S.A., INC. | $20.69 | 2020 | |
| Scynexis, INC. | $20.29 | 2022 | |
| Alydia Health | $18.82 | 2021 | |
| Vertical Pharmaceuticals, LLC | $18.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Cherry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.